The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control - Akiko, Y; Mikio, A; Machi, F (Diabetes research and clinical practice A., 2008)
et al.